Last week, we held an intensive Executive Sales Training Program at ISLE ACADEMY Bucharest, marking a key milestone in our journey with our long-standing partner, EDAP TMS, in the fight against one of the world’s most life-threatening diseases — prostate cancer.

The training focused on two innovative technologies revolutionizing the diagnosis and treatment of prostate cancer: FocalOne and ExactVu. From early, accurate diagnosis to targeted, non-invasive treatments, these solutions are setting new standards in patient care, helping clinicians make more precise decisions and empowering the future of prostate cancer therapy. Our goal is clear: broaden the understanding of the importance of accurate diagnosis and unlock the potential of Focal Therapy.

Together, we are preparing to advance healthcare systems by creating urgency in the adoption of these innovative technologies, ensuring clinicians have the best tools to provide efficient, non-invasive solutions.

The future of prostate cancer care is precise, patient focused, and empowered by innovation.

🔗 Learn more about FocalOne: here

🔗 Learn more about ExactVu: here